FDA label
What is solifenacin used for?
The FDA-approved uses of solifenacin, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted solifenacin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Solifenacin Succinate, tablet, film coated
Indications and Usage, quoted from the label by Ajanta Pharma USA Inc. (ANDA205483). Cross-references to other label sections are left out.
Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Source: DailyMed label, set id 9558ed7a-e942-4261-8aea-6033352f79b8, version 8, effective December 30, 2025. NDC 27241-037, one of 42 listings for this product.
Questions
What is solifenacin used for?
The FDA label says: “Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.”
What drug class is solifenacin?
FDA lists solifenacin in the Cholinergic Muscarinic Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.